How many clinical trials are running for dapagliflozin?

ClinicalTrials.gov lists more than 16 phase 2–4 dapagliflozin trials. This page tracks the 16 largest by enrolment: 1 phase 2, 7 phase 3, and 8 phase 4 among them, with 3 actively recruiting. Updated daily.

Are there clinical trials for Farxiga?

Farxiga is the brand name for dapagliflozin, so dapagliflozin trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 dapagliflozin trials. This page tracks the 16 largest by enrolment: 1 phase 2, 7 phase 3, and 8 phase 4 among them, with 3 actively recruiting. Updated daily.

Where does this data come from?

All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.

Can I compare dapagliflozin against other drugs?

Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Cardiometabolic & renal · Live ClinicalTrials.gov data

Dapagliflozin (Farxiga) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 dapagliflozin (Farxiga) trials on ClinicalTrials.gov by enrolment, 3 of them actively recruiting. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

Phase 3 trials

Actively recruiting

19,331

Participants across trials

AstraZeneca

Lead sponsor by trial count

dapagliflozin (16)6 active2009–2031

Hide completed

dapagliflozin

Key

Actual date

Anticipated

Forecast to primary completion

RecruitingNot yet recruitingCompletedUnknown status

'09

'11

'13

'15

'17

'19

'21

'23

'25

'27

'29

'31

dapagliflozin

Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus PatientsP2

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneP3

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With ForxigaP4

Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.P4

Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 DiabetesP4

DELIVERP3

DEANP3

BEYONDP4

DARE-19P3

DAPA-MIP3

DapaTAVIP4

Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle DysfunctionP3

ENVELOPP4

STAMI-BASP4

Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKDP3

ENAVO-AFP4

Upcoming readouts

3 ahead · dapagliflozin

Select a trial to load its full ClinicalTrials.gov record.

Key dapagliflozin trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

Trial	Title	Phase	Status	Primary completion
NCT06528262	ENAVO-AF: Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation	Phase 4	Recruiting	May 2027
NCT06562582	STAMI-BAS: STunning in Acute Myocardial Infarction - BAS	Phase 4	Recruiting	Dec 2027
NCT06642623	ENVELOP: A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellit…	Phase 4	Recruiting	Sept 2029
NCT02561130	Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga	Phase 4	Completed	Jul 2017
NCT04196231	BEYOND: Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basa…	Phase 4	Completed	Sept 2020
NCT04696185	DapaTAVI: Dapagliflozin After Transcatheter Aortic Valve Implantation	Phase 4	Completed	Dec 2024
NCT03377335	Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes	Phase 4	Unknown	Dec 2018
NCT02919059	Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.	Phase 4	Unknown	Dec 2018
NCT06820567	Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients Wit…	Phase 3	Not yet recruiting	Mar 2026
NCT01095666	A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are N…	Phase 3	Completed	Mar 2013
NCT04350593	DARE-19: Dapagliflozin in Respiratory Failure in Patients With COVID-19	Phase 3	Completed	Mar 2021
NCT03619213	DELIVER: Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart…	Phase 3	Completed	Mar 2022

Track dapagliflozin with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track dapagliflozin

Compare dapagliflozin vs empagliflozin Compare dapagliflozin vs finerenone

FAQ

How many clinical trials are running for dapagliflozin?: ClinicalTrials.gov lists more than 16 phase 2–4 dapagliflozin trials. This page tracks the 16 largest by enrolment: 1 phase 2, 7 phase 3, and 8 phase 4 among them, with 3 actively recruiting. Updated daily.
Are there clinical trials for Farxiga?: Farxiga is the brand name for dapagliflozin, so dapagliflozin trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 dapagliflozin trials. This page tracks the 16 largest by enrolment: 1 phase 2, 7 phase 3, and 8 phase 4 among them, with 3 actively recruiting. Updated daily.
Where does this data come from?: All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare dapagliflozin against other drugs?: Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.

Upcoming readouts

Key dapagliflozin trials

Track dapagliflozin with ComplyRx

Related drug pipelines

FAQ

Be the first to access ComplyRx